rs113867009

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006922.4(SCN3A):​c.4807+7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00234 in 1,613,728 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). The gene SCN3A is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.012 ( 42 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 45 hom. )

Consequence

SCN3A
NM_006922.4 splice_region, intron

Scores

3
Splicing: ADA: 0.00007579
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.178

Publications

0 publications found
Variant links:
Genes affected
SCN3A (HGNC:10590): (sodium voltage-gated channel alpha subunit 3) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is found in a cluster of five alpha subunit genes on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SCN3A Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen, Illumina
  • developmental and epileptic encephalopathy, 62
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy, familial focal, with variable foci 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006922.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-165092247-T-C is Benign according to our data. Variant chr2-165092247-T-C is described in ClinVar as Benign. ClinVar VariationId is 240711.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0125 (1900/152330) while in subpopulation AFR AF = 0.0418 (1737/41560). AF 95% confidence interval is 0.0402. There are 42 homozygotes in GnomAd4. There are 915 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1900 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006922.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN3A
NM_006922.4
MANE Select
c.4807+7A>G
splice_region intron
N/ANP_008853.3
SCN3A
NM_001081676.2
c.4660+7A>G
splice_region intron
N/ANP_001075145.1Q9NY46-4
SCN3A
NM_001081677.2
c.4660+7A>G
splice_region intron
N/ANP_001075146.1Q9NY46-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN3A
ENST00000283254.12
TSL:1 MANE Select
c.4807+7A>G
splice_region intron
N/AENSP00000283254.7Q9NY46-3
SCN3A
ENST00000409101.7
TSL:1
c.4660+7A>G
splice_region intron
N/AENSP00000386726.3Q9NY46-2
SCN3A
ENST00000706067.1
c.4756+7A>G
splice_region intron
N/AENSP00000516211.1A0A994J5P2

Frequencies

GnomAD3 genomes
AF:
0.0125
AC:
1900
AN:
152212
Hom.:
42
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0419
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00831
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00338
AC:
848
AN:
251140
AF XY:
0.00268
show subpopulations
Gnomad AFR exome
AF:
0.0445
Gnomad AMR exome
AF:
0.00284
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000159
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00128
AC:
1874
AN:
1461398
Hom.:
45
Cov.:
31
AF XY:
0.00113
AC XY:
824
AN XY:
727044
show subpopulations
African (AFR)
AF:
0.0422
AC:
1412
AN:
33444
American (AMR)
AF:
0.00300
AC:
134
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5766
European-Non Finnish (NFE)
AF:
0.000139
AC:
154
AN:
1111638
Other (OTH)
AF:
0.00258
AC:
156
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
100
199
299
398
498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0125
AC:
1900
AN:
152330
Hom.:
42
Cov.:
32
AF XY:
0.0123
AC XY:
915
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0418
AC:
1737
AN:
41560
American (AMR)
AF:
0.00824
AC:
126
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68040
Other (OTH)
AF:
0.00992
AC:
21
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
97
193
290
386
483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00607
Hom.:
6
Bravo
AF:
0.0142
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
SCN3A-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
7.6
DANN
Benign
0.84
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000076
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs113867009;
hg19: chr2-165948757;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.